Fast Five Quiz: Esophagitis

Previously, histamine-2 receptor antagonist therapy was recommended as the initial treatment for esophagitis associated with GERD; however, subsequent studies of cost-effectiveness and symptom relief suggested that PPIs are superior.

AGA guidelines for long-term PPI use recommend the following:

• Patients with uncomplicated GERD who respond to short-term PPIs should subsequently attempt to stop or reduce them. Patients who cannot reduce PPIs should consider ambulatory esophageal pH/impedance monitoring before committing to lifelong PPI therapy, to help distinguish GERD from a functional syndrome.

• Patients at high risk for ulcer-related bleeding from nonsteroidal anti-inflammatory drugs (NSAIDs) should take a PPI, if they continue to take NSAIDs.

• The dose of long-term PPIs should be periodically reevaluated so that the lowest effective PPI dose can be prescribed to manage the condition.

• Long-term PPI users should not routinely use probiotics to prevent infection.

• Long-term PPI users should not routinely raise their intake of calcium, vitamin B₁₂, or magnesium beyond the recommended dietary allowance.

• Long-term PPI users should not routinely screen or monitor bone mineral density, serum creatinine levels, magnesium levels, or vitamin B₁₂ levels.

• Specific PPI formulations should not be selected on the basis of potential risks.

Read more about PPI use in patients with esophagitis.

Medscape © 2020 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: B.S. Anand. Fast Five Quiz: Esophagitis - Medscape - Jul 14, 2020.